Tirzepatide — Powder
Third-Party Tested · Verified Purity · Fast U.S. Shipping
Tirzepatide — Research Peptide | CAS 2023788-19-2
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. As a 39-amino acid synthetic peptide, it represents a novel class of incretin-based compounds that have generated significant interest in metabolic and endocrine research.
Preclinical and published clinical research has examined tirzepatide's effects on pancreatic beta cell function, insulin sensitivity, energy expenditure, and adipose tissue metabolism. It is among the most actively studied peptides in the current obesity and metabolic syndrome research literature, distinguished by its dual-agonist mechanism compared to GLP-1 selective compounds.
Supplied as a lyophilized powder with ≥98% purity, HPLC-verified. Certificate of Analysis available. For research use only. Not for human consumption.